Legal & General Group Plc - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 130 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$48,000
-43.5%
14,090
-37.5%
0.00%
Q2 2018$85,000
-15.8%
22,546
-8.3%
0.00%
Q1 2018$101,000
-30.8%
24,580
-21.2%
0.00%
Q4 2017$146,000
-33.9%
31,2090.0%0.00%
Q3 2017$221,000
+8.9%
31,209
+10.7%
0.00%
Q2 2017$203,000
+26.1%
28,205
+8.5%
0.00%
Q1 2017$161,000
+6.6%
25,985
+1.2%
0.00%
Q4 2016$151,000
+24.8%
25,685
+11.4%
0.00%
Q3 2016$121,000
-24.4%
23,053
-4.6%
0.00%
Q2 2016$160,000
+41.6%
24,1750.0%0.00%
Q1 2016$113,000
-5.0%
24,175
-0.0%
0.00%
Q4 2015$119,000
+38.4%
24,1810.0%0.00%
Q3 2015$86,000
-56.8%
24,181
+18.9%
0.00%
Q2 2015$199,000
-3.9%
20,344
+25.5%
0.00%
Q1 2015$207,000
+5.1%
16,209
+17.9%
0.00%
Q4 2014$197,000
+5.3%
13,7480.0%0.00%
Q3 2014$187,00013,7480.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Foresite Capital Management I, LLC 1,312,006$16,990,00016.50%
VHCP Management, LLC 1,000,273$12,954,0006.97%
Cormorant Asset Management, LP 1,700,000$22,015,0006.39%
HARVEY CAPITAL MANAGEMENT INC 890,500$11,531,0004.76%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 859,672$11,133,0002.50%
Rhenman & Partners Asset Management AB 400,000$5,180,0002.03%
SECTORAL ASSET MANAGEMENT INC 2,758,950$35,728,0001.54%
NORTHPOINTE CAPITAL LLC 1,289,711$16,701,0001.47%
Knoll Capital Management, LLC 200,000$2,592,0001.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,483,260$19,208,0001.00%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders